Your browser doesn't support javascript.
loading
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension.
D'Addario, Catherine A; Matsumura, Shun; Kitagawa, Atsushi; Lainer, Gregg M; Zhang, Frank; D'silva, Melinee; Khan, Mohammad Y; Froogh, Ghezal; Gruzdev, Artiom; Zeldin, Darryl C; Schwartzman, Michal L; Gupte, Sachin A.
Afiliación
  • D'Addario CA; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Matsumura S; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Kitagawa A; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Lainer GM; Department of Cardiology, and Heart and Vascular Institute, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, USA.
  • Zhang F; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • D'silva M; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Khan MY; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Froogh G; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Gruzdev A; National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
  • Zeldin DC; National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
  • Schwartzman ML; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
  • Gupte SA; Department of Pharmacology, New York Medical College, Valhalla, NY 10595, USA. Electronic address: s_gupte@nymc.edu.
Vascul Pharmacol ; 153: 107235, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37742819
RATIONALE: Pulmonary hypertension (PH) is a multifactorial disease with a poor prognosis and inadequate treatment options. We found two-fold higher expression of the orphan G-Protein Coupled Receptor 75 (GPR75) in leukocytes and pulmonary arterial smooth muscle cells from idiopathic PH patients and from lungs of C57BL/6 mice exposed to hypoxia. We therefore postulated that GPR75 signaling is critical to the pathogenesis of PH. METHODS: To test this hypothesis, we exposed global (Gpr75-/-) and endothelial cell (EC) GPR75 knockout (EC-Gpr75-/-) mice and wild-type (control) mice to hypoxia (10% oxygen) or normal atmospheric oxygen for 5 weeks. We then recorded echocardiograms and performed right heart catheterizations. RESULTS: Chronic hypoxia increased right ventricular systolic and diastolic pressures in wild-type mice but not Gpr75-/- or EC-Gpr75-/- mice. In situ hybridization and qPCR results revealed that Gpr75 expression was increased in the alveoli, airways and pulmonary arteries of mice exposed to hypoxia. In addition, levels of chemokine (CC motif) ligand 5 (CCL5), a low affinity ligand of GPR75, were increased in the lungs of wild-type, but not Gpr75-/-, mice exposed to hypoxia, and CCL5 enhanced hypoxia-induced contraction of intra-lobar pulmonary arteries in a GPR75-dependent manner. Gpr75 knockout also increased pulmonary cAMP levels and decreased contraction of intra-lobar pulmonary arteries evoked by endothelin-1 or U46619 in cAMP-protein kinase A-dependent manner. CONCLUSION: These results suggest GPR75 has a significant role in the development of hypoxia-induced PH.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertensión Pulmonar Límite: Animals / Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertensión Pulmonar Límite: Animals / Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos